BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23307349)

  • 1. Ternary polymeric nanoparticles for oral siRNA delivery.
    Zhang J; He C; Tang C; Yin C
    Pharm Res; 2013 May; 30(5):1228-39. PubMed ID: 23307349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA
    Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L
    Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages.
    Xiao B; Ma P; Ma L; Chen Q; Si X; Walter L; Merlin D
    J Colloid Interface Sci; 2017 Mar; 490():520-528. PubMed ID: 27918990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.
    He C; Yin L; Tang C; Yin C
    Pharm Res; 2013 Oct; 30(10):2596-606. PubMed ID: 23715740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages.
    Zhang J; Tang C; Yin C
    Biomaterials; 2013 May; 34(14):3667-77. PubMed ID: 23419643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterisation of chitosan nanoparticles for siRNA delivery.
    Katas H; Alpar HO
    J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers.
    Raja MA; Katas H; Jing Wen T
    PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
    He C; Yin L; Song Y; Tang C; Yin C
    Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
    He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
    Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L; Ding J; He C; Cui L; Tang C; Yin C
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
    He C; Yin L; Tang C; Yin C
    Biomaterials; 2013 Apr; 34(11):2843-54. PubMed ID: 23347838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi using a chitosan/siRNA nanoparticle system: in vitro and in vivo applications.
    Andersen MØ; Howard KA; Kjems J
    Methods Mol Biol; 2009; 555():77-86. PubMed ID: 19495689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsp70 silencing with siRNA in nanocarriers enhances cancer cell death induced by the inhibitor of Hsp90.
    Matokanovic M; Barisic K; Filipovic-Grcic J; Maysinger D
    Eur J Pharm Sci; 2013 Sep; 50(1):149-58. PubMed ID: 23583203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan nanoparticles: Polyphosphates cross-linking and protein delivery properties.
    Abdelgawad AM; Hudson SM
    Int J Biol Macromol; 2019 Sep; 136():133-142. PubMed ID: 31199974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
    Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
    Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Transforming Growth Factor-β1 siRNA Loaded Chitosan-Tripolyphosphate Nanoparticles for the Treatment of Colorectal Cancer Hepatic Metastasis in a Mouse Model.
    Fang JK; Chen L; Lu XG; Cao D; Guo LL; Zhang YS; Li LB; Zhang LF; Kuang YT; Wang SL
    J Biomed Nanotechnol; 2016 Jul; 12(7):1489-1500. PubMed ID: 29337488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles.
    Chu S; Tang C; Yin C
    Biomaterials; 2015 Jun; 52():229-39. PubMed ID: 25818429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uniform Core-Shell Nanoparticles with Thiolated Hyaluronic Acid Coating to Enhance Oral Delivery of Insulin.
    Tian H; He Z; Sun C; Yang C; Zhao P; Liu L; Leong KW; Mao HQ; Liu Z; Chen Y
    Adv Healthc Mater; 2018 Sep; 7(17):e1800285. PubMed ID: 29984479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.